loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Imipenem

    Menu

    Imipenem

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,454Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 50587 / DOSAGE - POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL;250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CILASTATIN SODIUM(UNII: 5428WXZ74M)
    (CILASTATIN - UNII:141A6AMN38)     		CILASTATIN500mg in 100 | 500mg in 100
    IMIPENEM(UNII: 71OTZ9ZE0A)
    (IMIPENEM ANHYDROUS - UNII:Q20IM7HE75)     		IMIPENEM ANHYDROUS500mg in 100 | 500mg in 100

    Inactive Ingredients

    Ingredient Name
    Cardinal Health
    SODIUM BICARBONATE(8MDF5V39QO)